Sage sug­gests job and pipeline cuts af­ter FDA re­jec­tion of ma­jor de­pres­sion pill

Sage Ther­a­peu­tics an­nounced plans for a “pipeline pri­or­i­ti­za­tion and a work­force re­or­ga­ni­za­tion” on Mon­day morn­ing af­ter the FDA re­ject­ed its ex­per­i­men­tal pill for ma­jor de­pres­sive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER